Authors
Joseph Lam, MD, clinical professor in pediatrics and associate member of the Department of Dermatology and Skin Sciences, BC Children's Hospital at the University of British Columbia.
Pulmonary and critical care fellow, Temple University Hospital
Chance Scott is a Partner in the Guidehouse Life Sciences practice.
Advertisement
Advertisement
Trending on AJMC
1
EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology
2
MRD-Guided CLL Treatment Duration: Personalization or Malpractice?
3
Teclistamab Outperforms Len/Dex in High-Risk Smoldering Myeloma With Higher CR Rate, PFS: Omar Nadeem, MD
4
Tec-Dara Demonstrates Superior 3-Year PFS vs Standard Therapy in Functional High-Risk Myeloma: Rahul Banerjee, MD
5
